MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis.
about
Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approachCountry, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndromeThe Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platformThe Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment OptionsA comparative study on iMed(©) and European database for multiple sclerosis to propose a common language of multiple sclerosis data elements.A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data.Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).Data quality evaluation for observational multiple sclerosis registries.Neuroinflammation - using big data to inform clinical practice.Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase RegistryGeographical variations in sex ratio trends over time in multiple sclerosis.Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosisComparative efficacy of switching to natalizumab in active multiple sclerosis.Predictors of disability worsening in clinically isolated syndrome.Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MSDesigning an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation System.Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.Fingolimod after natalizumab and the risk of short-term relapse.Defining secondary progressive multiple sclerosis.Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.Treatment decisions in multiple sclerosis - insights from real-world observational studies.Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.Predictors of long-term disability accrual in relapse-onset multiple sclerosis.Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.Contribution of different relapse phenotypes to disability in multiple sclerosis.BREMSO: a simple score to predict early the natural course of multiple sclerosis.Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.The importance of collecting structured clinical information on multiple sclerosis.Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients.Predictors and dynamics of postpartum relapses in women with multiple sclerosis.SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts.Fair data for next-generation management of multiple sclerosis.Biogen's portfolio and research efforts in multiple sclerosis: an interview with Dr Ralph Kern.Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.Deep brain stimulation for severe treatment-resistant obsessive-compulsive disorder: An open-label case series.Feeling severely affected by multiple sclerosis: what does this mean?Cortical dysfunction underlies disability in multiple sclerosis.Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
P2860
Q28080043-C3E95493-F29F-4781-B290-3AAD360B52D8Q28480907-F4B7BF11-BBD7-4FC5-BA72-EC2C39F149EEQ28488248-09CB7495-D5C4-4A5C-B98F-B70989125581Q28601505-4FB1D786-D247-4B10-A47B-C8603D0A0799Q30881892-8BD8CF2B-86E4-402B-933E-96AA3E940E40Q31034192-1E0D7E1E-6418-4569-B013-1642D82B3C7FQ31115496-6CA4BC5A-A5A7-491B-B79D-F7079F752328Q31119031-322ED3E3-1A46-4DD5-954D-5469B30967A5Q31142833-E501D4F7-92C2-4A5E-8E14-6C57AB3B691CQ33613668-EAE76CF1-A5B8-42DE-8E76-958D5BBA5321Q34469310-7EAAA70B-BEF4-45D5-B6BC-DECD4DA42795Q34737478-B815D71E-DB7C-446F-9BB2-F8DF0C3E659CQ35469575-52C338FF-93CB-4505-9330-4BFF916C9A00Q35619185-BE290CB8-AF8D-4631-8CD8-A2B6FA2BC657Q35653675-AE925672-5C3E-473A-A186-9C034F3361ADQ36492533-6618F8CB-6695-454F-A34A-745D7F7C88D1Q36789883-02C91B8A-2C7B-4FD1-9750-5367EF0BD1C5Q37725909-D2E8D551-077B-4F42-9C47-BCE3C69F406FQ38843046-F92F7180-42EA-4AC6-9283-E85309F378BAQ38850911-DDECDF7A-A1C6-4765-83AD-781ECD74896FQ39022643-20529111-7BFC-4291-AE32-57CFD113FEF6Q39685700-DE871B19-45F4-40C2-A08B-75A939A7DD9BQ39795220-280F8B4B-52C9-4D5E-B2C7-BD18B6371FCEQ39900185-790E8762-DC2C-47AB-AA75-E07886D3F8B2Q40073097-55CC2119-3D92-45EB-BD46-865BEC9DF2A8Q40710140-D95B903D-473F-43B9-AC11-95B515D3E20BQ40724148-716B0617-5DAD-41FB-B849-0477B1079BBCQ41161179-CDCB8C12-DC1E-43A4-81DC-F1C92E302079Q41721827-A89FCE09-0B6E-468D-841E-88F0E338CFF5Q42747344-5FC31846-5E6D-48DF-AA61-20D15057B424Q45823287-48AD410E-CE2D-469F-BA33-EB587CFCE942Q45832934-E403D11D-5C46-4489-9334-8A5D502CDF9FQ46861116-697AF982-D16F-4949-BC9B-CE980C4AA7AEQ47288129-C773F303-A305-4EA7-BBEA-C3A8A257BE76Q47589453-4C17D5D3-A60E-4012-8560-7EC64FF4BAEEQ47639943-C7E6E569-CAB1-4EEB-9094-1A3B5FA075BCQ47671470-2621594F-35D9-47C8-BFEE-F4E0F4488ECCQ48557268-ACE9E143-CD88-4D2F-A4A7-3A0CECE6D0AFQ48866769-9D32BB8B-8A66-4DF4-8551-10AD8A4913F4Q48922719-7C26C18D-6090-4200-8CDA-69C8B2010361
P2860
MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
MSBase: an international, onli ...... esearch in multiple sclerosis.
@ast
MSBase: an international, onli ...... esearch in multiple sclerosis.
@en
type
label
MSBase: an international, onli ...... esearch in multiple sclerosis.
@ast
MSBase: an international, onli ...... esearch in multiple sclerosis.
@en
prefLabel
MSBase: an international, onli ...... esearch in multiple sclerosis.
@ast
MSBase: an international, onli ...... esearch in multiple sclerosis.
@en
P2093
P2860
P356
P1476
MSBase: an international, onli ...... esearch in multiple sclerosis.
@en
P2093
E Cristiano
F Grand'Maison
G Izquierdo
J P Malkowski
M Hoffmann
P2860
P304
P356
10.1177/1352458506070775
P577
2006-12-01T00:00:00Z